microRNA information: hsa-miR-135b-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-135b-5p | miRbase |
| Accession: | MIMAT0000758 | miRbase |
| Precursor name: | hsa-mir-135b | miRbase |
| Precursor accession: | MI0000810 | miRbase |
| Symbol: | MIR135B | HGNC |
| RefSeq ID: | NR_029893 | GenBank |
| Sequence: | UAUGGCUUUUCAUUCCUAUGUGA |
Reported expression in cancers: hsa-miR-135b-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-135b-5p | breast cancer | upregulation | "Quantitative reverse transcription polymerase chai ......" | 26934863 | Reverse transcription PCR; qPCR |
| hsa-miR-135b-5p | colon cancer | downregulation | "Among the miRNAs demonstrating the largest fold up ......" | 21694772 | |
| hsa-miR-135b-5p | colon cancer | upregulation | "MicroRNA 135b promotes cancer progression by actin ......" | 24735923 | |
| hsa-miR-135b-5p | colorectal cancer | upregulation | "Expression of miR 21 miR 31 miR 96 and miR 135b is ......" | 22844381 | qPCR |
| hsa-miR-135b-5p | colorectal cancer | upregulation | "MiR-135b has been shown to be upregulated in CRC. ......" | 24343340 | |
| hsa-miR-135b-5p | colorectal cancer | upregulation | "Identification of microRNA 135b in stool as a pote ......" | 24691020 | |
| hsa-miR-135b-5p | endometrial cancer | deregulation | "A set of EEC-associated miRNAs in tissue and plasm ......" | 24491411 | RNA-Seq |
| hsa-miR-135b-5p | gastric cancer | upregulation | "Clinicopathological significance and function of m ......" | 23328512 | Microarray; qPCR |
| hsa-miR-135b-5p | gastric cancer | upregulation | "MicroRNA microarray was applied to assess the miRN ......" | 24054006 | Microarray |
| hsa-miR-135b-5p | glioblastoma | downregulation | "Notably the average expression level of miR-135b w ......" | 26437223 | |
| hsa-miR-135b-5p | liver cancer | upregulation | "In this study we screened for the aberrant and fun ......" | 25537516 | |
| hsa-miR-135b-5p | prostate cancer | upregulation | "A trend of increased expression >40% of miR-135b a ......" | 18949015 | qPCR |
| hsa-miR-135b-5p | prostate cancer | downregulation | "In the present study significant downregulation of ......" | 26870245 | qPCR |
| hsa-miR-135b-5p | sarcoma | upregulation | "Here we demonstrated that compared with noncancero ......" | 25416447 |
Reported cancer pathway affected by hsa-miR-135b-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-135b-5p | breast cancer | cell cycle pathway | "miR 135b upregulated in breast cancer promotes cel ......" | 26934863 | Colony formation; Cell migration assay; MTT assay; Western blot; Luciferase |
| hsa-miR-135b-5p | cervical and endocervical cancer | cell cycle pathway | "Down regulation of microRNA 135b inhibited growth ......" | 26617737 | MTT assay; Flow cytometry; Western blot; Luciferase |
| hsa-miR-135b-5p | colon cancer | Apoptosis pathway | "MicroRNA 135b promotes cancer progression by actin ......" | 24735923 | |
| hsa-miR-135b-5p | colorectal cancer | Apoptosis pathway | "miR 135b Promotes Cancer Progression by Targeting ......" | 26061281 | |
| hsa-miR-135b-5p | colorectal cancer | Apoptosis pathway | "MicroRNA 135b regulates apoptosis and chemoresista ......" | 26101704 | |
| hsa-miR-135b-5p | gastric cancer | cell cycle pathway; Apoptosis pathway | "Clinicopathological significance and function of m ......" | 23328512 | Flow cytometry; Western blot |
| hsa-miR-135b-5p | retinoblastoma | cell cycle pathway | "To investigate differential expression of microRNA ......" | 21941147 |
Reported cancer prognosis affected by hsa-miR-135b-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-135b-5p | breast cancer | progression; metastasis | "Targeting of Runx2 by miR 135 and miR 203 Impairs ......" | 25634212 | |
| hsa-miR-135b-5p | breast cancer | cell migration; malignant trasformation | "miR 135b upregulated in breast cancer promotes cel ......" | 26934863 | Colony formation; Cell migration assay; MTT assay; Western blot; Luciferase |
| hsa-miR-135b-5p | breast cancer | poor survival | "In this multicenter study a 10-miRNA classifier in ......" | 27566954 | |
| hsa-miR-135b-5p | colon cancer | progression; staging | "MicroRNA 135b promotes cancer progression by actin ......" | 24735923 | |
| hsa-miR-135b-5p | colon cancer | staging | "We assessed by qRT-PCR expression of 754 microRNAs ......" | 27485175 | |
| hsa-miR-135b-5p | colorectal cancer | staging; metastasis; progression | "Expression of miR 21 miR 31 miR 96 and miR 135b is ......" | 22844381 | |
| hsa-miR-135b-5p | colorectal cancer | staging | "Genome-wide microarray analysis of miRNA expressio ......" | 23673725 | |
| hsa-miR-135b-5p | colorectal cancer | metastasis; cell migration; progression | "MicroRNA 135b regulates metastasis suppressor 1 ex ......" | 24343340 | Western blot; Luciferase |
| hsa-miR-135b-5p | colorectal cancer | staging | "Identification of microRNA 135b in stool as a pote ......" | 24691020 | |
| hsa-miR-135b-5p | colorectal cancer | metastasis | "Expression of miR-15b and miR-135b was significant ......" | 25557290 | |
| hsa-miR-135b-5p | colorectal cancer | progression | "miR 135b Promotes Cancer Progression by Targeting ......" | 26061281 | |
| hsa-miR-135b-5p | colorectal cancer | drug resistance | "MicroRNA 135b regulates apoptosis and chemoresista ......" | 26101704 | |
| hsa-miR-135b-5p | colorectal cancer | worse prognosis | "Screening miRNAs for early diagnosis of colorectal ......" | 27022275 | |
| hsa-miR-135b-5p | esophageal cancer | poor survival | "miRNAs were labeled and hybridized to the Illumina ......" | 22939244 | |
| hsa-miR-135b-5p | esophageal cancer | poor survival | "A large number of miRNAs were differentially expre ......" | 23477513 | |
| hsa-miR-135b-5p | gastric cancer | staging; metastasis; differentiation | "Clinicopathological significance and function of m ......" | 23328512 | Flow cytometry; Western blot |
| hsa-miR-135b-5p | gastric cancer | worse prognosis | "Whole mRNA expression levels were acquired from mi ......" | 24222951 | |
| hsa-miR-135b-5p | gastric cancer | poor survival | "Then we further investigated these GC specific miR ......" | 27173517 | |
| hsa-miR-135b-5p | glioblastoma | drug resistance | "miR 135b contributes to the radioresistance by tar ......" | 25265336 | |
| hsa-miR-135b-5p | glioblastoma | tumorigenesis; poor survival | "miR 135b suppresses tumorigenesis in glioblastoma ......" | 26437223 | |
| hsa-miR-135b-5p | head and neck cancer | poor survival | "MicroRNA 135b acts as a tumor promoter by targetin ......" | 23340180 | Colony formation |
| hsa-miR-135b-5p | liver cancer | staging | "Gα12gep oncogene inhibits FOXO1 in hepatocellular ......" | 24631529 | |
| hsa-miR-135b-5p | liver cancer | metastasis; cell migration; motility | "MicroRNA 135b a HSF1 target promotes tumor invasio ......" | 25537516 | |
| hsa-miR-135b-5p | liver cancer | metastasis | "miR 135b promotes the invasion and metastasis of h ......" | 26429530 | Western blot; Luciferase |
| hsa-miR-135b-5p | lung cancer | metastasis | "MicroRNA 135b promotes lung cancer metastasis by r ......" | 23695671 | |
| hsa-miR-135b-5p | lung squamous cell cancer | drug resistance | "miR 135b reverses chemoresistance of non small cel ......" | 27643554 | Luciferase |
| hsa-miR-135b-5p | lymphoma | drug resistance | "miR 135b mediates NPM ALK driven oncogenicity and ......" | 22042699 | |
| hsa-miR-135b-5p | melanoma | malignant trasformation | "MiR 135 post transcriptionally regulates FOXO1 exp ......" | 26261511 | |
| hsa-miR-135b-5p | prostate cancer | metastasis; staging | "miR 135b inhibits tumour metastasis in prostate ca ......" | 26870245 | Western blot; Luciferase |
| hsa-miR-135b-5p | sarcoma | malignant trasformation | "MicroRNA 135b promotes proliferation invasion and ......" | 25190111 | |
| hsa-miR-135b-5p | sarcoma | worse prognosis; metastasis; staging | "miR 135b a key regulator of malignancy is linked t ......" | 27157622 | |
| hsa-miR-135b-5p | thyroid cancer | tumor size | "To detect the levels of miRNA expression in fresh ......" | 23569392 |
Reported gene related to hsa-miR-135b-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-135b-5p | cervical and endocervical cancer | FOXO1 | "Down regulation of microRNA 135b inhibited growth ......" | 26617737 |
| hsa-miR-135b-5p | endometrial cancer | FOXO1 | "MiR 135b promotes proliferation of endometrial car ......" | 27222184 |
| hsa-miR-135b-5p | liver cancer | FOXO1 | "Gα12gep oncogene inhibits FOXO1 in hepatocellular ......" | 24631529 |
| hsa-miR-135b-5p | lymphoma | FOXO1 | "In turn elevated miR-135b targeted FOXO1 in ALCL c ......" | 22042699 |
| hsa-miR-135b-5p | melanoma | FOXO1 | "MiR 135 post transcriptionally regulates FOXO1 exp ......" | 26261511 |
| hsa-miR-135b-5p | sarcoma | FOXO1 | "MiR 135b promotes proliferation and invasion of os ......" | 25416447 |
| hsa-miR-135b-5p | colon cancer | APC | "We show that miR-135b overexpression is triggered ......" | 24735923 |
| hsa-miR-135b-5p | colorectal cancer | APC | "Regulation of the adenomatous polyposis coli gene ......" | 18632633 |
| hsa-miR-135b-5p | gastric cancer | APC | "Real-time quantitative PCR and Western blot were u ......" | 23328512 |
| hsa-miR-135b-5p | breast cancer | LATS2 | "miR 135b upregulated in breast cancer promotes cel ......" | 26934863 |
| hsa-miR-135b-5p | colorectal cancer | LATS2 | "In elucidating the molecular mechanism by which mi ......" | 26101704 |
| hsa-miR-135b-5p | colorectal cancer | ACAD8 | "In stool samples level of miR-135b was significant ......" | 24691020 |
| hsa-miR-135b-5p | glioblastoma | ADAM12 | "We identified ADAM12 and confirmed SMAD5 and GSK3Î ......" | 26437223 |
| hsa-miR-135b-5p | prostate cancer | AR | "MicroRNA 135b regulates ERα AR and HIF1AN and aff ......" | 25907805 |
| hsa-miR-135b-5p | colorectal cancer | CASR | "miR 135b and miR 146b dependent silencing of calci ......" | 26178670 |
| hsa-miR-135b-5p | cervical and endocervical cancer | CCND1 | "Besides miR-135b inhibition significantly increase ......" | 26617737 |
| hsa-miR-135b-5p | prostate cancer | ESR1 | "We wanted to further explore the relationship of m ......" | 25907805 |
| hsa-miR-135b-5p | liver cancer | EVI5 | "The reversion-inducing-cysteine-rich protein with ......" | 25537516 |
| hsa-miR-135b-5p | lung squamous cell cancer | FZD1 | "miR 135b reverses chemoresistance of non small cel ......" | 27643554 |
| hsa-miR-135b-5p | glioblastoma | GK | "MicroRNA 135b exerts oncogenic activity in gliobla ......" | 25936394 |
| hsa-miR-135b-5p | glioblastoma | GK5 | "It was revealed that GK5 is a target of miR-135b i ......" | 25936394 |
| hsa-miR-135b-5p | glioblastoma | GSC | "More importantly miR-135b restoration was able to ......" | 26437223 |
| hsa-miR-135b-5p | sarcoma | HCCS | "The expression levels of miR-135b and THBS2 signif ......" | 27157622 |
| hsa-miR-135b-5p | prostate cancer | HIF1AN | "MicroRNA 135b regulates ERα AR and HIF1AN and aff ......" | 25907805 |
| hsa-miR-135b-5p | liver cancer | HNF1A | "Furthermore we observed that heat shock transcript ......" | 25537516 |
| hsa-miR-135b-5p | liver cancer | HSF1 | "Furthermore we observed that heat shock transcript ......" | 25537516 |
| hsa-miR-135b-5p | glioblastoma | INSR | "In addition clinical data indicated that the expre ......" | 25265336 |
| hsa-miR-135b-5p | liver cancer | JUNB | "Gα12QL increased the primary form of miR-135b by ......" | 24631529 |
| hsa-miR-135b-5p | lymphoma | LEMD1 | "NPM-ALK oncogene strongly promoted the expression ......" | 22042699 |
| hsa-miR-135b-5p | lung cancer | LZTS1 | "MicroRNA 135b promotes lung cancer metastasis by r ......" | 23695671 |
| hsa-miR-135b-5p | colorectal cancer | MTSS1 | "MicroRNA 135b regulates metastasis suppressor 1 ex ......" | 24343340 |
| hsa-miR-135b-5p | colorectal cancer | MTUS1 | "Accordingly some of the overexpressed miRNAs espec ......" | 26643896 |
| hsa-miR-135b-5p | sarcoma | MYOCD | "MicroRNA 135b promotes proliferation invasion and ......" | 25190111 |
| hsa-miR-135b-5p | cervical and endocervical cancer | PCNA | "Besides miR-135b inhibition significantly increase ......" | 26617737 |
| hsa-miR-135b-5p | liver cancer | RECK | "The reversion-inducing-cysteine-rich protein with ......" | 25537516 |
| hsa-miR-135b-5p | breast cancer | RUNX2 | "Targeting of Runx2 by miR 135 and miR 203 Impairs ......" | 25634212 |
| hsa-miR-135b-5p | glioblastoma | SMAD5 | "We identified ADAM12 and confirmed SMAD5 and GSK3Î ......" | 26437223 |
| hsa-miR-135b-5p | lymphoma | SOAT1 | "NPM-ALK oncogene strongly promoted the expression ......" | 22042699 |
| hsa-miR-135b-5p | colon cancer | SRC | "We show that miR-135b overexpression is triggered ......" | 24735923 |
| hsa-miR-135b-5p | prostate cancer | STAT6 | "miR 135b inhibits tumour metastasis in prostate ca ......" | 26870245 |
| hsa-miR-135b-5p | colorectal cancer | TGFBR2 | "miR 135b Promotes Cancer Progression by Targeting ......" | 26061281 |
| hsa-miR-135b-5p | sarcoma | THBS2 | "The expression levels of miR-135b and THBS2 signif ......" | 27157622 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-135b-5p | NBEA | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.14; TCGA COAD -0.424; TCGA ESCA -0.344; TCGA HNSC -0.351; TCGA KIRP -0.218; TCGA LUSC -0.094; TCGA PAAD -0.412; TCGA THCA -0.253; TCGA STAD -0.463; TCGA UCEC -0.219 |
hsa-miR-135b-5p | THRB | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUSC; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.119; TCGA COAD -0.276; TCGA ESCA -0.194; TCGA HNSC -0.302; TCGA KIRP -0.178; TCGA LUSC -0.101; TCGA OV -0.133; TCGA STAD -0.25; TCGA UCEC -0.227 |
hsa-miR-135b-5p | ZNF135 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.195; TCGA CESC -0.239; TCGA COAD -0.289; TCGA ESCA -0.367; TCGA HNSC -0.343; TCGA KIRC -0.076; TCGA KIRP -0.14; TCGA LUAD -0.112; TCGA PAAD -0.287; TCGA STAD -0.35; TCGA UCEC -0.11 |
hsa-miR-135b-5p | ANGPTL2 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.137; TCGA CESC -0.165; TCGA COAD -0.276; TCGA ESCA -0.126; TCGA HNSC -0.236; TCGA KIRC -0.127; TCGA KIRP -0.276; TCGA LUAD -0.095; TCGA OV -0.094; TCGA STAD -0.192; TCGA UCEC -0.071 |
hsa-miR-135b-5p | NAP1L2 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.145; TCGA CESC -0.321; TCGA COAD -0.49; TCGA ESCA -0.551; TCGA HNSC -0.308; TCGA KIRP -0.247; TCGA PAAD -0.572; TCGA THCA -0.113; TCGA STAD -0.541; TCGA UCEC -0.312 |
hsa-miR-135b-5p | BHLHB9 | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRP; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.053; TCGA CESC -0.13; TCGA ESCA -0.064; TCGA HNSC -0.114; TCGA KIRP -0.211; TCGA PAAD -0.181; TCGA THCA -0.077; TCGA STAD -0.082; TCGA UCEC -0.079 |
hsa-miR-135b-5p | JAKMIP2 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.174; TCGA CESC -0.155; TCGA COAD -0.329; TCGA ESCA -0.287; TCGA HNSC -0.29; TCGA LUAD -0.141; TCGA LUSC -0.408; TCGA PAAD -0.438; TCGA STAD -0.373; TCGA UCEC -0.084 |
hsa-miR-135b-5p | ZCCHC24 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.202; TCGA CESC -0.088; TCGA COAD -0.206; TCGA ESCA -0.274; TCGA HNSC -0.324; TCGA KIRP -0.149; TCGA LUSC -0.091; TCGA OV -0.091; TCGA PAAD -0.087; TCGA THCA -0.063; TCGA STAD -0.305; TCGA UCEC -0.26 |
hsa-miR-135b-5p | RGL1 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.113; TCGA CESC -0.179; TCGA COAD -0.17; TCGA ESCA -0.139; TCGA HNSC -0.123; TCGA KIRC -0.126; TCGA KIRP -0.196; TCGA LUSC -0.068; TCGA PAAD -0.279; TCGA STAD -0.19; TCGA UCEC -0.109 |
hsa-miR-135b-5p | SLC9A9 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.13; TCGA CESC -0.354; TCGA COAD -0.389; TCGA ESCA -0.358; TCGA HNSC -0.153; TCGA LUSC -0.141; TCGA PAAD -0.317; TCGA THCA -0.215; TCGA STAD -0.302; TCGA UCEC -0.218 |
hsa-miR-135b-5p | PDE8B | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.118; TCGA CESC -0.139; TCGA COAD -0.286; TCGA ESCA -0.135; TCGA HNSC -0.148; TCGA KIRP -0.269; TCGA LUSC -0.102; TCGA PAAD -0.308; TCGA THCA -0.346; TCGA STAD -0.273; TCGA UCEC -0.287 |
hsa-miR-135b-5p | PKHD1L1 | 10 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.263; TCGA COAD -0.513; TCGA ESCA -0.356; TCGA HNSC -0.368; TCGA LUAD -0.215; TCGA LUSC -0.371; TCGA PAAD -0.602; TCGA THCA -1.324; TCGA STAD -0.475; TCGA UCEC -0.407 |
hsa-miR-135b-5p | GRK5 | 10 cancers: BLCA; CESC; KIRC; KIRP; LUAD; LUSC; OV; THCA; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.083; TCGA CESC -0.097; TCGA KIRC -0.12; TCGA KIRP -0.112; TCGA LUAD -0.143; TCGA LUSC -0.131; TCGA OV -0.113; TCGA THCA -0.21; TCGA STAD -0.088; TCGA UCEC -0.219 |
hsa-miR-135b-5p | ARHGEF6 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.087; TCGA CESC -0.14; TCGA COAD -0.358; TCGA ESCA -0.202; TCGA HNSC -0.269; TCGA KIRC -0.076; TCGA KIRP -0.188; TCGA LUSC -0.169; TCGA PAAD -0.243; TCGA THCA -0.177; TCGA STAD -0.229; TCGA UCEC -0.202 |
hsa-miR-135b-5p | ZNF385B | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.141; TCGA CESC -0.324; TCGA COAD -0.485; TCGA ESCA -0.527; TCGA HNSC -0.4; TCGA KIRC -0.188; TCGA KIRP -0.366; TCGA OV -0.269; TCGA PAAD -0.214; TCGA STAD -0.395; TCGA UCEC -0.139 |
hsa-miR-135b-5p | DLG2 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.288; TCGA CESC -0.427; TCGA COAD -0.407; TCGA ESCA -0.43; TCGA HNSC -0.458; TCGA KIRP -0.212; TCGA LUAD -0.098; TCGA PAAD -0.471; TCGA THCA -0.481; TCGA STAD -0.458; TCGA UCEC -0.312 |
hsa-miR-135b-5p | SLC8A1 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.187; TCGA CESC -0.121; TCGA COAD -0.262; TCGA ESCA -0.18; TCGA HNSC -0.204; TCGA KIRP -0.341; TCGA LUAD -0.083; TCGA PAAD -0.398; TCGA THCA -0.119; TCGA STAD -0.267; TCGA UCEC -0.159 |
hsa-miR-135b-5p | ARHGAP6 | 10 cancers: BLCA; CESC; COAD; HNSC; KIRP; LUAD; LUSC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.125; TCGA CESC -0.168; TCGA COAD -0.151; TCGA HNSC -0.389; TCGA KIRP -0.191; TCGA LUAD -0.073; TCGA LUSC -0.193; TCGA THCA -0.214; TCGA STAD -0.202; TCGA UCEC -0.293 |
hsa-miR-135b-5p | MAPRE2 | 10 cancers: BLCA; HNSC; KIRC; KIRP; LUSC; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.086; TCGA HNSC -0.185; TCGA KIRC -0.142; TCGA KIRP -0.263; TCGA LUSC -0.085; TCGA OV -0.096; TCGA PAAD -0.144; TCGA THCA -0.295; TCGA STAD -0.055; TCGA UCEC -0.068 |
hsa-miR-135b-5p | WSCD2 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.235; TCGA CESC -0.297; TCGA COAD -0.504; TCGA ESCA -0.712; TCGA HNSC -0.561; TCGA KIRP -0.375; TCGA OV -0.319; TCGA PAAD -0.217; TCGA THCA -1.291; TCGA STAD -0.593; TCGA UCEC -0.325 |
hsa-miR-135b-5p | GPR155 | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; THCA; STAD | MirTarget | TCGA BLCA -0.129; TCGA CESC -0.153; TCGA ESCA -0.374; TCGA HNSC -0.156; TCGA KIRP -0.379; TCGA LUAD -0.079; TCGA LUSC -0.066; TCGA PAAD -0.256; TCGA THCA -0.378; TCGA STAD -0.282 |
hsa-miR-135b-5p | DIP2C | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.084; TCGA COAD -0.199; TCGA ESCA -0.104; TCGA HNSC -0.164; TCGA KIRC -0.16; TCGA KIRP -0.213; TCGA PAAD -0.122; TCGA THCA -0.321; TCGA STAD -0.195; TCGA UCEC -0.084 |
hsa-miR-135b-5p | MYOCD | 9 cancers: BLCA; CESC; COAD; ESCA; KIRP; LUSC; PAAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.414; TCGA CESC -0.341; TCGA COAD -0.54; TCGA ESCA -0.451; TCGA KIRP -0.408; TCGA LUSC -0.321; TCGA PAAD -0.299; TCGA STAD -0.517; TCGA UCEC -0.599 |
hsa-miR-135b-5p | BSN | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; STAD | MirTarget | TCGA BLCA -0.112; TCGA COAD -0.139; TCGA ESCA -0.145; TCGA HNSC -0.167; TCGA KIRP -0.112; TCGA LUAD -0.106; TCGA LUSC -0.143; TCGA PAAD -0.508; TCGA STAD -0.145 |
hsa-miR-135b-5p | KCNQ5 | 10 cancers: BLCA; CESC; COAD; ESCA; KIRC; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.242; TCGA CESC -0.393; TCGA COAD -0.368; TCGA ESCA -0.525; TCGA KIRC -0.218; TCGA OV -0.307; TCGA PAAD -0.322; TCGA THCA -0.287; TCGA STAD -0.427; TCGA UCEC -0.172 |
hsa-miR-135b-5p | PSIP1 | 11 cancers: BLCA; CESC; COAD; ESCA; KIRP; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.071; TCGA CESC -0.079; TCGA COAD -0.061; TCGA ESCA -0.106; TCGA KIRP -0.067; TCGA LUAD -0.133; TCGA LUSC -0.119; TCGA OV -0.078; TCGA PAAD -0.238; TCGA STAD -0.09; TCGA UCEC -0.074 |
hsa-miR-135b-5p | MEF2C | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.181; TCGA CESC -0.175; TCGA COAD -0.283; TCGA ESCA -0.159; TCGA HNSC -0.444; TCGA KIRC -0.112; TCGA KIRP -0.134; TCGA LUSC -0.153; TCGA PAAD -0.238; TCGA THCA -0.168; TCGA STAD -0.232; TCGA UCEC -0.23 |
hsa-miR-135b-5p | ADCYAP1 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.326; TCGA CESC -0.184; TCGA COAD -0.5; TCGA ESCA -0.369; TCGA HNSC -0.183; TCGA KIRP -0.196; TCGA PAAD -0.596; TCGA STAD -0.522; TCGA UCEC -0.252 |
hsa-miR-135b-5p | MAN1A1 | 11 cancers: BLCA; COAD; HNSC; KIRP; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.184; TCGA COAD -0.193; TCGA HNSC -0.247; TCGA KIRP -0.334; TCGA LUAD -0.131; TCGA LUSC -0.092; TCGA OV -0.175; TCGA PAAD -0.388; TCGA THCA -0.169; TCGA STAD -0.101; TCGA UCEC -0.154 |
hsa-miR-135b-5p | SH2D3C | 11 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.104; TCGA CESC -0.131; TCGA COAD -0.224; TCGA ESCA -0.149; TCGA KIRC -0.146; TCGA KIRP -0.139; TCGA LUSC -0.156; TCGA PAAD -0.25; TCGA THCA -0.161; TCGA STAD -0.105; TCGA UCEC -0.148 |
hsa-miR-135b-5p | RAB33B | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.056; TCGA CESC -0.07; TCGA ESCA -0.053; TCGA HNSC -0.057; TCGA KIRP -0.056; TCGA LUSC -0.122; TCGA PAAD -0.066; TCGA STAD -0.066; TCGA UCEC -0.132 |
hsa-miR-135b-5p | FOXN3 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.097; TCGA CESC -0.154; TCGA COAD -0.172; TCGA ESCA -0.186; TCGA HNSC -0.192; TCGA KIRC -0.105; TCGA KIRP -0.207; TCGA LUSC -0.119; TCGA OV -0.114; TCGA PAAD -0.15; TCGA THCA -0.068; TCGA STAD -0.203; TCGA UCEC -0.211 |
hsa-miR-135b-5p | FGFR1 | 10 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.256; TCGA COAD -0.283; TCGA ESCA -0.24; TCGA HNSC -0.282; TCGA LUAD -0.142; TCGA LUSC -0.118; TCGA PAAD -0.24; TCGA THCA -0.085; TCGA STAD -0.245; TCGA UCEC -0.072 |
hsa-miR-135b-5p | TNS1 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.259; TCGA CESC -0.111; TCGA COAD -0.372; TCGA ESCA -0.392; TCGA HNSC -0.367; TCGA KIRC -0.151; TCGA KIRP -0.239; TCGA LUSC -0.215; TCGA PAAD -0.143; TCGA THCA -0.201; TCGA STAD -0.395; TCGA UCEC -0.212 |
hsa-miR-135b-5p | FKBP5 | 9 cancers: BLCA; CESC; COAD; ESCA; KIRP; LUAD; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.117; TCGA CESC -0.1; TCGA COAD -0.196; TCGA ESCA -0.271; TCGA KIRP -0.165; TCGA LUAD -0.112; TCGA PAAD -0.295; TCGA STAD -0.25; TCGA UCEC -0.084 |
hsa-miR-135b-5p | TBL1X | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.063; TCGA CESC -0.08; TCGA ESCA -0.088; TCGA HNSC -0.105; TCGA KIRC -0.06; TCGA KIRP -0.165; TCGA LUSC -0.07; TCGA PAAD -0.176; TCGA THCA -0.064; TCGA STAD -0.065; TCGA UCEC -0.137 |
hsa-miR-135b-5p | ASPA | 10 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.297; TCGA COAD -0.474; TCGA ESCA -0.494; TCGA KIRC -0.198; TCGA KIRP -0.27; TCGA LUSC -0.175; TCGA PAAD -0.33; TCGA THCA -0.384; TCGA STAD -0.384; TCGA UCEC -0.4 |
hsa-miR-135b-5p | SLC1A2 | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRP; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.182; TCGA COAD -0.211; TCGA ESCA -0.229; TCGA HNSC -0.127; TCGA KIRP -0.169; TCGA PAAD -0.369; TCGA THCA -0.481; TCGA STAD -0.219; TCGA UCEC -0.083 |
hsa-miR-135b-5p | IGFBP5 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; STAD; UCEC | mirMAP | TCGA BLCA -0.161; TCGA CESC -0.306; TCGA COAD -0.345; TCGA ESCA -0.261; TCGA HNSC -0.451; TCGA KIRP -0.347; TCGA LUAD -0.118; TCGA STAD -0.253; TCGA UCEC -0.258 |
hsa-miR-135b-5p | AKAP12 | 9 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; THCA; STAD | mirMAP | TCGA BLCA -0.26; TCGA COAD -0.272; TCGA ESCA -0.242; TCGA HNSC -0.428; TCGA LUAD -0.267; TCGA LUSC -0.178; TCGA PAAD -0.15; TCGA THCA -0.332; TCGA STAD -0.345 |
hsa-miR-135b-5p | ENTPD1 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.111; TCGA CESC -0.085; TCGA COAD -0.191; TCGA ESCA -0.064; TCGA HNSC -0.086; TCGA KIRC -0.079; TCGA LUSC -0.072; TCGA PAAD -0.088; TCGA STAD -0.115; TCGA UCEC -0.091 |
hsa-miR-135b-5p | ACVRL1 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.108; TCGA COAD -0.096; TCGA ESCA -0.08; TCGA HNSC -0.205; TCGA KIRC -0.076; TCGA LUAD -0.099; TCGA LUSC -0.166; TCGA PAAD -0.127; TCGA THCA -0.205; TCGA STAD -0.067; TCGA UCEC -0.111 |
hsa-miR-135b-5p | NTRK3 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.382; TCGA CESC -0.317; TCGA COAD -0.416; TCGA ESCA -0.379; TCGA HNSC -0.453; TCGA KIRP -0.216; TCGA PAAD -0.231; TCGA STAD -0.463; TCGA UCEC -0.324 |
hsa-miR-135b-5p | NFIC | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.06; TCGA CESC -0.157; TCGA COAD -0.188; TCGA ESCA -0.185; TCGA HNSC -0.259; TCGA KIRC -0.063; TCGA KIRP -0.282; TCGA LUSC -0.095; TCGA PAAD -0.132; TCGA STAD -0.145; TCGA UCEC -0.127 |
hsa-miR-135b-5p | GFRA1 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; THCA; STAD | mirMAP | TCGA BLCA -0.298; TCGA CESC -0.326; TCGA COAD -0.541; TCGA ESCA -0.435; TCGA HNSC -0.615; TCGA LUSC -0.219; TCGA PAAD -0.354; TCGA THCA -0.598; TCGA STAD -0.597 |
hsa-miR-135b-5p | MMP16 | 9 cancers: BLCA; CESC; COAD; HNSC; KIRC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.092; TCGA CESC -0.159; TCGA COAD -0.306; TCGA HNSC -0.33; TCGA KIRC -0.148; TCGA OV -0.147; TCGA PAAD -0.233; TCGA STAD -0.222; TCGA UCEC -0.122 |
hsa-miR-135b-5p | PTCHD1 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.544; TCGA CESC -0.2; TCGA COAD -0.416; TCGA ESCA -0.396; TCGA HNSC -0.292; TCGA LUSC -0.221; TCGA OV -0.311; TCGA PAAD -0.219; TCGA STAD -0.623; TCGA UCEC -0.223 |
hsa-miR-135b-5p | FAT3 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.35; TCGA CESC -0.289; TCGA COAD -0.302; TCGA ESCA -0.493; TCGA HNSC -0.229; TCGA KIRP -0.483; TCGA LUAD -0.235; TCGA PAAD -0.136; TCGA STAD -0.535; TCGA UCEC -0.142 |
hsa-miR-135b-5p | TUB | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.207; TCGA CESC -0.365; TCGA COAD -0.311; TCGA ESCA -0.52; TCGA HNSC -0.352; TCGA KIRC -0.205; TCGA KIRP -0.335; TCGA LUSC -0.147; TCGA PAAD -0.335; TCGA THCA -0.135; TCGA STAD -0.365; TCGA UCEC -0.312 |
hsa-miR-135b-5p | PRTG | 10 cancers: BLCA; COAD; HNSC; KIRP; LUAD; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.283; TCGA COAD -0.38; TCGA HNSC -0.322; TCGA KIRP -0.184; TCGA LUAD -0.143; TCGA LUSC -0.165; TCGA PAAD -0.15; TCGA THCA -0.357; TCGA STAD -0.241; TCGA UCEC -0.121 |
hsa-miR-135b-5p | SHE | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.176; TCGA COAD -0.36; TCGA ESCA -0.204; TCGA HNSC -0.283; TCGA KIRC -0.11; TCGA KIRP -0.262; TCGA LUSC -0.202; TCGA PAAD -0.317; TCGA STAD -0.225; TCGA UCEC -0.25 |
hsa-miR-135b-5p | SIK2 | 10 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; STAD | mirMAP | TCGA BLCA -0.053; TCGA ESCA -0.093; TCGA HNSC -0.109; TCGA KIRC -0.062; TCGA KIRP -0.168; TCGA LUAD -0.086; TCGA LUSC -0.055; TCGA PAAD -0.109; TCGA THCA -0.062; TCGA STAD -0.08 |
hsa-miR-135b-5p | LONRF2 | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.442; TCGA COAD -0.539; TCGA ESCA -0.385; TCGA HNSC -0.562; TCGA KIRP -0.179; TCGA LUSC -0.178; TCGA PAAD -0.266; TCGA STAD -0.401; TCGA UCEC -0.223 |
hsa-miR-135b-5p | GJC1 | 11 cancers: BLCA; CESC; COAD; ESCA; KIRC; LUAD; OV; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.099; TCGA CESC -0.197; TCGA COAD -0.239; TCGA ESCA -0.129; TCGA KIRC -0.199; TCGA LUAD -0.125; TCGA OV -0.187; TCGA PAAD -0.168; TCGA THCA -0.195; TCGA STAD -0.232; TCGA UCEC -0.258 |
hsa-miR-135b-5p | SLIT3 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUSC; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.259; TCGA CESC -0.176; TCGA COAD -0.415; TCGA ESCA -0.317; TCGA HNSC -0.308; TCGA KIRP -0.277; TCGA LUSC -0.168; TCGA PAAD -0.342; TCGA STAD -0.29; TCGA UCEC -0.07 |
hsa-miR-135b-5p | VGLL3 | 11 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.239; TCGA CESC -0.177; TCGA COAD -0.338; TCGA ESCA -0.216; TCGA HNSC -0.354; TCGA LUAD -0.163; TCGA LUSC -0.144; TCGA OV -0.222; TCGA THCA -0.206; TCGA STAD -0.225; TCGA UCEC -0.371 |
hsa-miR-135b-5p | C17orf51 | 9 cancers: BLCA; ESCA; KIRP; LUAD; OV; PAAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.091; TCGA ESCA -0.124; TCGA KIRP -0.101; TCGA LUAD -0.091; TCGA OV -0.072; TCGA PAAD -0.339; TCGA THCA -0.208; TCGA STAD -0.171; TCGA UCEC -0.131 |
hsa-miR-135b-5p | PLEKHO2 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; PAAD; STAD | mirMAP | TCGA BLCA -0.081; TCGA CESC -0.054; TCGA COAD -0.189; TCGA ESCA -0.121; TCGA HNSC -0.077; TCGA KIRC -0.071; TCGA LUAD -0.08; TCGA PAAD -0.061; TCGA STAD -0.123 |
hsa-miR-135b-5p | PTPRD | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; PAAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.288; TCGA CESC -0.181; TCGA COAD -0.353; TCGA ESCA -0.266; TCGA HNSC -0.419; TCGA LUSC -0.249; TCGA PAAD -0.287; TCGA STAD -0.232; TCGA UCEC -0.244 |
hsa-miR-135b-5p | SETBP1 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; PAAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.078; TCGA CESC -0.141; TCGA COAD -0.371; TCGA ESCA -0.349; TCGA HNSC -0.118; TCGA KIRP -0.142; TCGA PAAD -0.382; TCGA THCA -0.123; TCGA STAD -0.374; TCGA UCEC -0.158 |
hsa-miR-135b-5p | MRAS | 11 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.18; TCGA COAD -0.273; TCGA ESCA -0.207; TCGA HNSC -0.302; TCGA LUAD -0.127; TCGA LUSC -0.093; TCGA OV -0.146; TCGA PAAD -0.121; TCGA THCA -0.087; TCGA STAD -0.212; TCGA UCEC -0.084 |
hsa-miR-135b-5p | PCYT1B | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.158; TCGA CESC -0.324; TCGA COAD -0.207; TCGA ESCA -0.413; TCGA HNSC -0.294; TCGA LUAD -0.147; TCGA LUSC -0.171; TCGA PAAD -0.243; TCGA STAD -0.288; TCGA UCEC -0.128 |
hsa-miR-135b-5p | ROR1 | 11 cancers: BLCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.104; TCGA CESC -0.179; TCGA COAD -0.277; TCGA HNSC -0.353; TCGA KIRC -0.135; TCGA KIRP -0.317; TCGA LUAD -0.081; TCGA LUSC -0.142; TCGA PAAD -0.166; TCGA STAD -0.165; TCGA UCEC -0.202 |
hsa-miR-135b-5p | MAFB | 9 cancers: CESC; COAD; ESCA; HNSC; KIRP; LUAD; PAAD; THCA; STAD | miRNAWalker2 validate | TCGA CESC -0.206; TCGA COAD -0.287; TCGA ESCA -0.195; TCGA HNSC -0.089; TCGA KIRP -0.115; TCGA LUAD -0.069; TCGA PAAD -0.348; TCGA THCA -0.284; TCGA STAD -0.127 |
hsa-miR-135b-5p | APC | 9 cancers: CESC; HNSC; KIRC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | miRTarBase; MirTarget | TCGA CESC -0.069; TCGA HNSC -0.101; TCGA KIRC -0.069; TCGA KIRP -0.216; TCGA LUSC -0.086; TCGA PAAD -0.153; TCGA THCA -0.154; TCGA STAD -0.098; TCGA UCEC -0.066 |
hsa-miR-135b-5p | STX12 | 9 cancers: CESC; ESCA; HNSC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.073; TCGA ESCA -0.081; TCGA HNSC -0.059; TCGA KIRP -0.088; TCGA LUSC -0.087; TCGA PAAD -0.088; TCGA THCA -0.083; TCGA STAD -0.059; TCGA UCEC -0.096 |
hsa-miR-135b-5p | SETD7 | 11 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | MirTarget; mirMAP | TCGA CESC -0.062; TCGA COAD -0.063; TCGA ESCA -0.068; TCGA HNSC -0.182; TCGA KIRC -0.071; TCGA KIRP -0.137; TCGA LUSC -0.106; TCGA PAAD -0.077; TCGA THCA -0.118; TCGA STAD -0.153; TCGA UCEC -0.218 |
hsa-miR-135b-5p | PPM1F | 10 cancers: CESC; COAD; ESCA; KIRC; KIRP; LUAD; PAAD; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.089; TCGA COAD -0.083; TCGA ESCA -0.06; TCGA KIRC -0.139; TCGA KIRP -0.076; TCGA LUAD -0.086; TCGA PAAD -0.087; TCGA THCA -0.065; TCGA STAD -0.072; TCGA UCEC -0.096 |
hsa-miR-135b-5p | LANCL1 | 9 cancers: CESC; ESCA; HNSC; KIRP; LUAD; PAAD; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.093; TCGA ESCA -0.091; TCGA HNSC -0.083; TCGA KIRP -0.158; TCGA LUAD -0.092; TCGA PAAD -0.053; TCGA THCA -0.088; TCGA STAD -0.057; TCGA UCEC -0.073 |
hsa-miR-135b-5p | VLDLR | 11 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; STAD | MirTarget | TCGA CESC -0.224; TCGA COAD -0.299; TCGA ESCA -0.179; TCGA HNSC -0.103; TCGA KIRC -0.143; TCGA KIRP -0.173; TCGA LUAD -0.07; TCGA LUSC -0.083; TCGA PAAD -0.255; TCGA THCA -0.437; TCGA STAD -0.307 |
hsa-miR-135b-5p | FOXO1 | 10 cancers: CESC; COAD; ESCA; HNSC; KIRP; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.085; TCGA COAD -0.074; TCGA ESCA -0.066; TCGA HNSC -0.138; TCGA KIRP -0.107; TCGA OV -0.08; TCGA PAAD -0.147; TCGA THCA -0.144; TCGA STAD -0.075; TCGA UCEC -0.088 |
hsa-miR-135b-5p | SCN2A | 9 cancers: CESC; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA CESC -0.32; TCGA ESCA -0.277; TCGA HNSC -0.272; TCGA KIRP -0.195; TCGA LUAD -0.16; TCGA LUSC -0.228; TCGA PAAD -0.157; TCGA STAD -0.148; TCGA UCEC -0.209 |
hsa-miR-135b-5p | MTSS1 | 9 cancers: CESC; COAD; ESCA; KIRC; KIRP; PAAD; THCA; STAD; UCEC | MirTarget | TCGA CESC -0.241; TCGA COAD -0.102; TCGA ESCA -0.21; TCGA KIRC -0.068; TCGA KIRP -0.238; TCGA PAAD -0.148; TCGA THCA -0.157; TCGA STAD -0.174; TCGA UCEC -0.06 |
hsa-miR-135b-5p | SNX29 | 10 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; PAAD; THCA; STAD; UCEC | mirMAP | TCGA CESC -0.057; TCGA COAD -0.072; TCGA ESCA -0.106; TCGA HNSC -0.059; TCGA KIRC -0.104; TCGA KIRP -0.099; TCGA PAAD -0.167; TCGA THCA -0.2; TCGA STAD -0.144; TCGA UCEC -0.062 |
hsa-miR-135b-5p | NDST1 | 10 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; PAAD; THCA; STAD | mirMAP | TCGA CESC -0.09; TCGA COAD -0.089; TCGA ESCA -0.088; TCGA HNSC -0.08; TCGA KIRC -0.081; TCGA KIRP -0.153; TCGA LUAD -0.06; TCGA PAAD -0.226; TCGA THCA -0.083; TCGA STAD -0.059 |
hsa-miR-135b-5p | KATNAL1 | 10 cancers: CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA CESC -0.073; TCGA COAD -0.091; TCGA ESCA -0.161; TCGA HNSC -0.083; TCGA LUAD -0.078; TCGA LUSC -0.057; TCGA OV -0.108; TCGA PAAD -0.199; TCGA STAD -0.215; TCGA UCEC -0.129 |
hsa-miR-135b-5p | RAPGEF1 | 11 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; STAD | mirMAP | TCGA CESC -0.053; TCGA COAD -0.089; TCGA ESCA -0.083; TCGA HNSC -0.079; TCGA KIRC -0.134; TCGA KIRP -0.111; TCGA LUAD -0.088; TCGA LUSC -0.079; TCGA PAAD -0.105; TCGA THCA -0.117; TCGA STAD -0.067 |
hsa-miR-135b-5p | MDGA1 | 9 cancers: CESC; COAD; ESCA; KIRP; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA CESC -0.205; TCGA COAD -0.291; TCGA ESCA -0.397; TCGA KIRP -0.176; TCGA LUSC -0.256; TCGA PAAD -0.24; TCGA THCA -0.192; TCGA STAD -0.224; TCGA UCEC -0.141 |
hsa-miR-135b-5p | ZHX3 | 10 cancers: CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; THCA; STAD | mirMAP | TCGA CESC -0.088; TCGA COAD -0.107; TCGA ESCA -0.139; TCGA HNSC -0.131; TCGA KIRP -0.076; TCGA LUAD -0.062; TCGA LUSC -0.072; TCGA PAAD -0.247; TCGA THCA -0.099; TCGA STAD -0.145 |
hsa-miR-135b-5p | ROCK1 | 10 cancers: COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA COAD -0.085; TCGA ESCA -0.077; TCGA HNSC -0.089; TCGA KIRC -0.051; TCGA KIRP -0.136; TCGA LUAD -0.104; TCGA LUSC -0.119; TCGA PAAD -0.057; TCGA STAD -0.077; TCGA UCEC -0.068 |
hsa-miR-135b-5p | SLC31A2 | 9 cancers: COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; UCEC | MirTarget | TCGA COAD -0.171; TCGA ESCA -0.089; TCGA KIRC -0.11; TCGA KIRP -0.136; TCGA LUAD -0.121; TCGA LUSC -0.071; TCGA PAAD -0.152; TCGA THCA -0.146; TCGA UCEC -0.056 |
hsa-miR-135b-5p | SNTA1 | 10 cancers: COAD; ESCA; HNSC; KIRC; KIRP; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA COAD -0.139; TCGA ESCA -0.166; TCGA HNSC -0.141; TCGA KIRC -0.127; TCGA KIRP -0.274; TCGA OV -0.163; TCGA PAAD -0.145; TCGA THCA -0.318; TCGA STAD -0.217; TCGA UCEC -0.092 |
hsa-miR-135b-5p | DPP8 | 9 cancers: COAD; HNSC; KIRP; LUAD; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA COAD -0.091; TCGA HNSC -0.15; TCGA KIRP -0.242; TCGA LUAD -0.082; TCGA LUSC -0.06; TCGA PAAD -0.099; TCGA THCA -0.171; TCGA STAD -0.055; TCGA UCEC -0.071 |
hsa-miR-135b-5p | IL6ST | 9 cancers: COAD; ESCA; HNSC; KIRP; LUSC; PAAD; THCA; STAD; UCEC | mirMAP | TCGA COAD -0.272; TCGA ESCA -0.115; TCGA HNSC -0.34; TCGA KIRP -0.475; TCGA LUSC -0.155; TCGA PAAD -0.288; TCGA THCA -0.213; TCGA STAD -0.169; TCGA UCEC -0.196 |
Enriched cancer pathways of putative targets